Mapping international drug use by looking at wastewater

Wastewater-based epidemiology is a rapidly developing scientific discipline with the potential for monitoring close to real-time, population-level trends in illicit drug use. By sampling a known source of wastewater, such as a sewage influent to a wastewater treatment plant, scientists can estimate the quantity of drugs used in a community from the measured levels of illicit drugs and their metabolites excreted in urine. The results of the international monitoring campaigns performed annually over seven years (2011-2017) by an international group of scientists, the SCORE group (Sewage analysis CORe group Europe), are now compiled in an article published in the prestigious journal Addiction.

Drug use data from 37 countries around the world

In total, wastewater from over 60 million people in 120 cities from 37 countries was analyzed at least once over a one-week period to explore spatial population-level trends in the use of four illicit substances (amphetamine, methamphetamine, ecstasy, cocaine). Two Canadian cities in Quebec, Montreal and Granby, were monitored and contributed to building a core data set that allowed scientists to assess temporal trends in drug-taking behaviours.

“Participating in the SCORE project allowed us to contribute to the development of best practices for the implementation of the wastewater-based epidemiology as well as contributing to an international data set on geographical and temporal trends on drugs consumption, said Viviane Yargeau, from McGill University’s Department of Chemical Engineering. “The expertise developed was also instrumental in designing and conducting the pilot project that Statistics Canada started in March 2018 on the monitoring of drug consumption through wastewater analysis in order to collect additional data in the context of the legalization of cannabis.”

Different countries, different drug habits

The findings confirm the wide differences in drug use around the world:

  • Methamphetamine dominated the drug landscape in cities monitored in North America (United States and Canada) and Australasia (Australia, New Zealand and South Korea), with average levels exceeding by far those found in eastern Europe.
  • For both Granby and Montreal, consumption was generally around or below the average for all cities included in the study, except for methamphetamine for which both cities were part of the dominant cities.
  • The consumption of methamphetamine, although low on average when compared to other stimulants, presented some localized hot-spots in eastern cities (in Slovakia, Czech Republic and east of Germany) and it is being expanded to the north and centre of Europe.
  • Cocaine dominates the drug use scenario in southern and western cities (in Switzerland, Italy, France, Spain, United Kingdom), and its levels underwent an upsurge over 2011-2017 in most of the sampled sites.
  • Belgium and The Netherlands reported also a very high use of cocaine and of amphetamine, a substance that also increased its consumption in many northern European countries.
  • In South America (Colombia and Martinique) cocaine prevailed over the other substances. No temporal trends could be discerned in this case due to the recent inclusion of non-European sites in the international monitoring campaigns.
  • Ecstasy does not dominate any drug scenario, but its use was increased over the period 2011-2017 in most of the cities where it was reported.

Source: Read Full Article